Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMEXHS LIMITED Director's Dealing 2024

Feb 14, 2024

65120_rns_2024-02-14_baba0e80-ea36-4673-bf46-7b40dfa94666.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity ImExHS Limited
ABN 60 096 687 839

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Douglas Lingard
Date of last notice 17 November 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Direct and Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest. 1. Ilewise Pty Ltd <Lingard Super Fund A/C> (director related entityand beneficiary)2. Ilewise Pty Ltd <Lingard Family Trust A/C> (director relatedentity and beneficiary)
Date of change 13 February 2024
No. of securities held priorto change Direct40,000 options exercisable at $2.65, expiring 9/12/2023 and subject tovesting conditions20,044 nil price options vesting immediately, expiring 18/07/202639,726 nil price options vesting immediately, expiring 16/05/2027129,358 fully paid ordinary sharesIndirect1. 1,126,928 fully paid ordinary shares2. 375,000 fully paid ordinary shares
Class Fully paid ordinary shares
Number acquired 23,754
Number disposed -
  • See chapter 19 for defined terms.

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration $9,990
includes brokerage/gst
Note: If consideration is non-cash, provide
details and estimated valuation
No. of securities held after Direct
change 40,000 options exercisable at $2.65, expiring 9/12/2023 and subject to
vesting conditions
20,044 nil price options vesting immediately, expiring 18/07/2026
39,726 nil price options vesting immediately, expiring 16/05/2027
153,112 fully paid ordinary shares
Indirect
1. 1,126,928 fully paid ordinary shares
2. 375,000 fully paid ordinaryshares
Nature of change Issue of Ordinary Shares in lieu of non-executive Director fees for the
Example: on-market trade, off-market trade,exercise of options, issue of securities under quarter ending 31 December 2023.
dividend reinvestment plan, participation in
buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest N/A
Name of registered holder N/A
(if issued securities
Date of change N/A
No. and class of securities to which N/A
interest related prior to change
Note: Details are only required for a contract in relation to which
the interest has changed
Interest acquired N/A
Interest disposed N/A
Value/Consideration N/A
Note: If consideration is non-cash, provide details and an
estimated valuation
Interest after change N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts No detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow N/A the trade to proceed during this period? If prior written clearance was provided, on what N/A date was this provided?

  • See chapter 19 for defined terms.

Appendix 3Y Page 2